Intravenous L-arginine reduces VE/VCO2 slope acutely in patients with severe chronic heart failure

Eur J Heart Fail. 1999 Jun;1(2):187-90. doi: 10.1016/s1388-9842(99)00013-6.

Authors

A P Banning¹, B Prendergast

Affiliation

¹ Department of Cardiology, University Hospital of Wales, Heath Park, Cardiff, UK.

PMID: 10937929
DOI: 10.1016/s1388-9842(99)00013-6

No abstract available

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial

MeSH terms

Arginine / administration & dosage*
Blood Pressure / drug effects
Breath Tests
Carbon Dioxide / analysis*
Chronic Disease
Cross-Over Studies
Exercise Test
Heart Failure / drug therapy*
Heart Failure / metabolism
Heart Failure / physiopathology
Heart Rate / drug effects
Humans
Injections, Intravenous
Male
Middle Aged
Nifedipine / administration & dosage
Prognosis
Pulmonary Gas Exchange / drug effects*
Severity of Illness Index
Single-Blind Method
Vasodilator Agents / administration & dosage

Substances

Vasodilator Agents
Carbon Dioxide
Arginine
Nifedipine